Zentek Ltd. Common Stock (ZTEK) is a publicly traded Healthcare sector company. As of May 19, 2026, ZTEK trades at $0.74 with a market cap of $74.21M and a P/E ratio of 0.00. ZTEK moved +0.00% today. Year to date, ZTEK is +10.12%; over the trailing twelve months it is -53.46%. Its 52-week range spans $0.40 to $1.84. Rallies surfaces ZTEK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Zentek Secures C$15M Oversubscribed Financing to Advance Albany Graphite and ZenGUARD: Zentek raised C$15 million through an oversubscribed offering of 15 million units priced at C$1.00 each, plus an option to issue up to 3 million additional units. Proceeds will fund a new Preliminary Economic Assessment for its Albany Graphite Project, advance ZenGUARD commercialization and support working capital.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $74.21M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.84 |
| 52-Week Low | $0.40 |
| Volume | 108.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
ZTEK analyst coverage data. Average price target: $0.00.